PAI-1 promoter 4G/5G polymorphism (rs1799768) contributes to tumor susceptibility: Evidence from meta-analysis

Plasminogen activator inhibitor-1 (PAI-1), belonging to the urokinase plasminogen activation (uPA) system, is involved in cancer development and progression. The PAI-1 promoter 4G/5G polymorphism was shown to contribute to genetic susceptibility to cancer, although the results were inconsistent. To...

Descripción completa

Detalles Bibliográficos
Autores principales: XU, XIN, XIE, YANQI, LIN, YIWEI, XU, XIANGLAI, ZHU, YI, MAO, YEQING, HU, ZHENGHUI, WU, JIAN, CHEN, HONG, ZHENG, XIANGYI, QIN, JIE, XIE, LIPING
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2012
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494103/
https://www.ncbi.nlm.nih.gov/pubmed/23226787
http://dx.doi.org/10.3892/etm.2012.734

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3494103/
https://www.ncbi.nlm.nih.gov/pubmed/23226787
http://dx.doi.org/10.3892/etm.2012.734

Ejemplares similares